mokshtra cv dds syrup

Description

Effective Pediatric Antibiotic for Bacterial Infections

Mokshtra CV DDS Dry Syrup combines Amoxicillin 200 mg and Clavulanic Acid 28.5 mg per 5 ml reconstituted dose, targeting a broad spectrum of bacterial pathogens. The clavulanic acid component protects amoxicillin from β‑lactamase–producing bacteria.

🔹 Indications include:

• Acute otitis media, sinusitis & throat infections

• Lower respiratory tract infections including pneumonia

• Skin and soft tissue infections (e.g., dental, cellulitis)

• Urinary tract infections (particularly pediatric cases)

• Mixed bacterial infections resistant to amoxicillin alone

💊 Key Benefits:

• Broad‑spectrum action with β‑lactamase inhibition

• Convenient oral suspension ideal for children

• Effective in ENT, chest, dental, skin & urinary infections

• Well tolerated in pediatric patients

🧴 Administration & Dosage:

• Reconstitute powder with specified amount of water

• Shake well before use

• Administer with meals to reduce gastric upset

• Dose to be determined by physician based on age, body weight, and infection severity

⚠️ Common Side Effects:

• Nausea, vomiting, diarrhea, abdominal discomfort

• Possible thrush (oral or vaginal) or rash

• Rare but serious: allergic reactions, liver enzyme abnormalities

⚠️ Precautions & Warnings:

• Contraindicated in patients with penicillin allergy

• Use with caution in hepatic or renal impairment

• Complete the full prescribed course—even if symptoms improve—to prevent bacterial resistance

📝 Storage Instructions:
Store dry powder below 30°C. Once mixed, refrigerate and discard unused syrup after 7–10 days

👨‍⚕️ Ideal For:

• Children prescribed a β‑lactam/β‑lactamase‑inhibitor antibiotic

• Pediatric ENT, respiratory, dental or urinary infections

• Cases requiring improved spectrum beyond amoxicillin alone

✅ Substitutes:

Available alternatives include Moxicot‑CV DDS, Moxate‑CV 228.5, Moxal‑CV DDS, which share the same active components and indications